Impact of Cancer on Cardiovascular Health
Introduction
Recent advancements in diagnostics and therapies have enhanced survival rates for patients suffering from cancer and cardiovascular diseases. However, the occurrence of complications related to these conditions remains alarmingly high.
Chemotherapy and Cardiovascular Risks
Research over the years has established that chemotherapy can elevate the risk of cardiovascular problems, such as angina, heart attacks, and the exacerbation of coronary artery disease. This connection has prompted numerous studies to explore the interplay between cancer and cardiac health.
Study Overview
In a notable study published in the European Heart Journal, Potts and colleagues examined the health outcomes of cancer patients undergoing percutaneous coronary intervention (PCI). PCI is a catheter-based, non-surgical procedure that involves the insertion of a stent to alleviate narrowed blood vessels. The analysis included data from 6,571,034 PCI procedures performed between 2004 and 2014.
Research Findings
The researchers monitored various in-hospital outcomes post-PCI, including mortality, cardiac complications, postoperative strokes, bleeding, and vascular issues. The findings revealed that patients with a current cancer diagnosis experienced poorer clinical outcomes compared to those without a cancer history. Specifically, a current diagnosis of lung cancer was linked to heightened in-hospital complications and mortality. Patients with colon and prostate cancers demonstrated increased complications and bleeding, respectively. Interestingly, a current breast cancer diagnosis did not correlate with increased mortality or complications.
Furthermore, when controlling for confounding variables, a historical diagnosis of lung cancer also showed an association with adverse outcomes. Overall, the study indicated that cancer patients faced worse clinical outcomes than non-cancer patients undergoing PCI, with the severity of outcomes varying based on the cancer type and whether the diagnosis was current or historical.
Conclusion
These results underscore the necessity for heightened vigilance and care when treating cancer patients undergoing PCI to reduce the risk of complications.
Reference
Potts, J. E., Iliescu, C. A., Lopez Mattei, J. C., Martinez, S. C., Holmvang, L., Ludman, P., … & Mamas, M. A. (2018). Percutaneous coronary intervention in cancer patients: a report of the prevalence and outcomes in the United States. European Heart Journal.